Volume 5, Problème 6 (2015)
Méthodologie du parcours clinique
Clinical trial end points relevant to patients and society for rare cancers
Shelize Khakoo, Alexandros Georgiou & Ian Chau
Évaluation des médicaments
Ferric citrate in end-stage kidney disease as a phosphate binder and source of iron: a review of clinical trials
Diana I Jalal, Mohammed Sika, Jamie P Dwyer, Ingrid J Chang, Barbara A Greco, Marvin Sinsakul, Simin Goral & Kausik Umanath
Perspective du parcours clinique
Is social media suitable for patient recruitment?
Wolfgang Eglmeier
Évaluation des médicaments
Velaglucerase alfa in the treatment of Gaucher disease type 1: an update
K Nicole Weaver, Gregory A Grabowski & Thomas A Burrow
Perspective du parcours clinique
Monitoring randomized clinical trials in Africa; pragmatic approaches and experiences from HIV trials
Margaret J Thomason, Moira J Spyer1, Nicola Joffe1, Justine Boles, Andy Burke, Helen C Wilkes & Mary Rauchenberger
Évaluation des médicaments
Updating the clinical evidence on belimumab role modulating B-cell response and treatment of systemic lupus erythematosus
Ignasi Rodriguez-Pinto, Gerard Espinosa1 & Ricard Cervera
